OHDSI Home | Forums | Wiki | Github

OHDSI's odyssey: The journey ahead

General
#1

In his state of the collaborative address, @Patrick_Ryan highlighted the following as areas he’d like to see OHDSI focus on in 2017:

  • Generate and disseminate more clinical evidence
  • Maintain and evolve open community data and vocabulary standards
  • Develop and improve tools to enable large-scale analysis
  • Establish and promote community best practices
  • Strengthen and expand collaborations across OHDSI research network
  • Advance scholarship in observational data science through publication, presentations, and education
  • Generate and disseminate more clinical evidence

Given what we’ve accomplished as a community in 2016, and how our community continues to grow, I have no doubt 2017 will be an impressive year for OHDSI. One exciting milestone on the horizon is our face-to-face meeting in March. Leading up to that meeting, we’d like to open the floor up to you, our OHDSI collaborators, and ask what you guys hope to achieve, as a community, in 2017. Please feel free to respond to this thread and let us know:

  1. Goals you’d like to see OHDSI strive for in 2017.
  2. Possible challenges on the road ahead.
  3. Possible opportunities to strengthen collaboration and community engagement.
1 Like
#2

where can i find a such public list and actual contents of already generated clinical evidence ?

#3

A list of ongoing and complete OHDSI network research studies is available under the research tab on OHDSI.org:
http://www.ohdsi.org/network-research-studies/

A list of OHDSI publications is also available here:
http://www.ohdsi.org/resources/publications/

#4

Goals you’d like to see OHDSI strive for in 2017.

It would be nice to demostrate the value of big data to healthcare consumers. See my other post on ‘patient questions’ and if our OMOP CDM data can today answer some of those. Have a mechanism to collect “spam free” and “reasonable” patient questions.

#5
  1. Continue to increase healthcare data science community competency in OMOP CDM - further training offerings + sharing of best practices for standardization
  2. Increase real world data utilization across the life sciences industry through strategic partnerships and opportunities to publish
  3. Continue to promote ex-US CDM conversions (i.e. in some of those rich European longitudinal data sets) to support need to substantiate evidence in global regulatory context
  1. Consistency in conversion methodologies - more transparency into areas where certain types of concepts are difficult to map and require subject matter input / deliberation; need to collate chains from OHDSI forum into documentation for repeated use
  2. Lack of regulatory guidance for industry
  1. Increase OHDSI footprint in conference or other evidence proceedings outside of the “usual suspects” (i.e. continue to bring OHDSI evidence studies to new forums)
  2. OMOP in Sweden??? :slight_smile: (I hear this is a thing!!)
t